Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 9/2017

Open Access 01-09-2017 | Original Article

Virulence factors of Shiga toxin-producing Escherichia coli and the risk of developing haemolytic uraemic syndrome in Norway, 1992–2013

Authors: U. Naseer, I. Løbersli, M. Hindrum, T. Bruvik, L. T. Brandal

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 9/2017

Login to get access

Abstract

Shiga toxin-producing Escherichia coli (STEC) may cause haemolytic uraemic syndrome (HUS). Age ≤5 years and presence of stx2a and eae are risk factors for the development of HUS. In this study, we investigated STEC isolates for the presence of adhesins, toxins and molecular risk assessment (MRA) factors to identify virulence genes associated with HUS development. We included non-duplicate isolates from all STEC infections (n = 340, HUS = 32) reported to the Norwegian National Reference Laboratory (NRL) for Enteropathogenic Bacteria from 1992 to 2013. The most common STEC were O157:H7/H (34%) and O103:H2 (14%). We retrospectively screened the isolates by three multiplex polymerase chain reactions (PCRs) for adhesins (n = 11), toxins (n = 5) and MRA (n = 15). We calculated odds ratios (ORs) and adjusted odds ratios (aORs) for associations with HUS development. On average, isolates were positive for 15 virulence genes (range: 1–24); two toxins (range: 0–4), five adhesins (range: 0–8) and eight MRA genes (range: 0–13). The gene combinations were clustered within serotypes. Isolates from HUS cases were positive for eae and IpfA O26, and negative for saa, eibG, astA, cnf, subA and pic. We identified 11 virulence genes with a significant association to HUS development. Multivariable analyses adjusted for age group and Shiga toxin identified nleH1–2 [aOR 8.4, 95% confidence interval (CI); 2.18–32.3] as an independent risk factor for the development of HUS from an STEC infection. This study demonstrated that the non-LEE effector protein nleH1–2 may be an important predictor for elevated risk of developing HUS from STEC infections. We recommend the NRL for Enteropathogenic Bacteria to consider including nleH1–2 screening as part of routine STEC surveillance.
Appendix
Available only for authorised users
Literature
4.
go back to reference Persson S, Olsen KEP, Ethelberg S, Scheutz F (2007) Subtyping method for Escherichia coli shiga toxin (verocytotoxin) 2 variants and correlations to clinical manifestations. J Clin Microbiol 45(6):2020–2024CrossRefPubMedPubMedCentral Persson S, Olsen KEP, Ethelberg S, Scheutz F (2007) Subtyping method for Escherichia coli shiga toxin (verocytotoxin) 2 variants and correlations to clinical manifestations. J Clin Microbiol 45(6):2020–2024CrossRefPubMedPubMedCentral
5.
go back to reference Brandal LT, Wester AL, Lange H, Løbersli I, Lindstedt BA, Vold L, Kapperud G (2015) Shiga toxin-producing Escherichia coli infections in Norway, 1992–2012: characterization of isolates and identification of risk factors for haemolytic uremic syndrome. BMC Infect Dis 15:324. doi:10.1186/s12879-015-1017-6 CrossRefPubMedPubMedCentral Brandal LT, Wester AL, Lange H, Løbersli I, Lindstedt BA, Vold L, Kapperud G (2015) Shiga toxin-producing Escherichia coli infections in Norway, 1992–2012: characterization of isolates and identification of risk factors for haemolytic uremic syndrome. BMC Infect Dis 15:324. doi:10.​1186/​s12879-015-1017-6 CrossRefPubMedPubMedCentral
6.
go back to reference Boerlin P, McEwen SA, Boerlin-Petzold F, Wilson JB, Johnson RP, Gyles CL (1999) Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol 37(3):497–503PubMedPubMedCentral Boerlin P, McEwen SA, Boerlin-Petzold F, Wilson JB, Johnson RP, Gyles CL (1999) Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol 37(3):497–503PubMedPubMedCentral
8.
9.
go back to reference McDaniel TK, Jarvis KG, Donnenberg MS, Kaper JB (1995) A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc Natl Acad Sci U S A 92(5):1664–1668CrossRefPubMedPubMedCentral McDaniel TK, Jarvis KG, Donnenberg MS, Kaper JB (1995) A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc Natl Acad Sci U S A 92(5):1664–1668CrossRefPubMedPubMedCentral
12.
go back to reference Karmali MA, Mascarenhas M, Shen S, Ziebell K, Johnson S, Reid-Smith R, Isaac-Renton J, Clark C, Rahn K, Kaper JB (2003) Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease. J Clin Microbiol 41(11):4930–4940CrossRefPubMedPubMedCentral Karmali MA, Mascarenhas M, Shen S, Ziebell K, Johnson S, Reid-Smith R, Isaac-Renton J, Clark C, Rahn K, Kaper JB (2003) Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease. J Clin Microbiol 41(11):4930–4940CrossRefPubMedPubMedCentral
13.
go back to reference Coombes BK, Wickham ME, Mascarenhas M, Gruenheid S, Finlay BB, Karmali MA (2008) Molecular analysis as an aid to assess the public health risk of non-O157 Shiga toxin-producing Escherichia coli strains. Appl Environ Microbiol 74(7):2153–2160. doi:10.1128/AEM.02566-07 CrossRefPubMedPubMedCentral Coombes BK, Wickham ME, Mascarenhas M, Gruenheid S, Finlay BB, Karmali MA (2008) Molecular analysis as an aid to assess the public health risk of non-O157 Shiga toxin-producing Escherichia coli strains. Appl Environ Microbiol 74(7):2153–2160. doi:10.​1128/​AEM.​02566-07 CrossRefPubMedPubMedCentral
16.
go back to reference Brandt SM, King N, Cornelius AJ, Premaratne A, Besser TE, On SL (2011) Molecular risk assessment and epidemiological typing of Shiga toxin-producing Escherichia coli by using a novel PCR binary typing system. Appl Environ Microbiol 77(7):2458–2470. doi:10.1128/AEM.02322-10 CrossRefPubMedPubMedCentral Brandt SM, King N, Cornelius AJ, Premaratne A, Besser TE, On SL (2011) Molecular risk assessment and epidemiological typing of Shiga toxin-producing Escherichia coli by using a novel PCR binary typing system. Appl Environ Microbiol 77(7):2458–2470. doi:10.​1128/​AEM.​02322-10 CrossRefPubMedPubMedCentral
17.
go back to reference Andersson T, Nilsson C, Kjellin E, Toljander J, Welinder-Olsson C, Lindmark H (2011) Modeling gene associations for virulence classification of verocytotoxin-producing E. coli (VTEC) from patients and beef. Virulence 2(1):41–53CrossRefPubMed Andersson T, Nilsson C, Kjellin E, Toljander J, Welinder-Olsson C, Lindmark H (2011) Modeling gene associations for virulence classification of verocytotoxin-producing E. coli (VTEC) from patients and beef. Virulence 2(1):41–53CrossRefPubMed
18.
go back to reference Bugarel M, Beutin L, Fach P (2010) Low-density macroarray targeting non-locus of enterocyte effacement effectors (nle genes) and major virulence factors of Shiga toxin-producing Escherichia coli (STEC): a new approach for molecular risk assessment of STEC isolates. Appl Environ Microbiol 76(1):203–211. doi:10.1128/AEM.01921-09 CrossRefPubMed Bugarel M, Beutin L, Fach P (2010) Low-density macroarray targeting non-locus of enterocyte effacement effectors (nle genes) and major virulence factors of Shiga toxin-producing Escherichia coli (STEC): a new approach for molecular risk assessment of STEC isolates. Appl Environ Microbiol 76(1):203–211. doi:10.​1128/​AEM.​01921-09 CrossRefPubMed
19.
go back to reference Brandal LT, Lindstedt BA, Aas L, Stavnes TL, Lassen J, Kapperud G (2007) Octaplex PCR and fluorescence-based capillary electrophoresis for identification of human diarrheagenic Escherichia coli and Shigella spp. J Microbiol Methods 68(2):331–341. doi:10.1016/j.mimet.2006.09.013 CrossRefPubMed Brandal LT, Lindstedt BA, Aas L, Stavnes TL, Lassen J, Kapperud G (2007) Octaplex PCR and fluorescence-based capillary electrophoresis for identification of human diarrheagenic Escherichia coli and Shigella spp. J Microbiol Methods 68(2):331–341. doi:10.​1016/​j.​mimet.​2006.​09.​013 CrossRefPubMed
20.
go back to reference Ethelberg S, Olsen KEP, Scheutz F, Jensen C, Schiellerup P, Enberg J, Petersen AM, Olesen B, Gerner-Smidt P, Mølbak K (2004) Virulence factors for hemolytic uremic syndrome, Denmark. Emerg Infect Dis 10(5):842–847CrossRefPubMedPubMedCentral Ethelberg S, Olsen KEP, Scheutz F, Jensen C, Schiellerup P, Enberg J, Petersen AM, Olesen B, Gerner-Smidt P, Mølbak K (2004) Virulence factors for hemolytic uremic syndrome, Denmark. Emerg Infect Dis 10(5):842–847CrossRefPubMedPubMedCentral
21.
go back to reference Mellmann A, Bielaszewska M, Köck R, Friedrich AW, Fruth A, Middendorf B, Harmsen D, Schmidt MA, Karch H (2008) Analysis of collection of hemolytic uremic syndrome-associated enterohemorrhagic Escherichia coli. Emerg Infect Dis 14(8):1287–1290CrossRefPubMedPubMedCentral Mellmann A, Bielaszewska M, Köck R, Friedrich AW, Fruth A, Middendorf B, Harmsen D, Schmidt MA, Karch H (2008) Analysis of collection of hemolytic uremic syndrome-associated enterohemorrhagic Escherichia coli. Emerg Infect Dis 14(8):1287–1290CrossRefPubMedPubMedCentral
22.
go back to reference Friedrich AW, Bielaszewska M, Zhang W-L, Pulz M, Kuczius T, Ammon A, Karch H (2002) Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J infect Dis 185(1):74–84CrossRefPubMed Friedrich AW, Bielaszewska M, Zhang W-L, Pulz M, Kuczius T, Ammon A, Karch H (2002) Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J infect Dis 185(1):74–84CrossRefPubMed
23.
go back to reference Gould LH, Mody RK, Ong KL, Clogher P, Cronquist AB, Garman KN, Lathrop S, Medus C, Spina NL, Webb TH, White PL, Wymore K, Gierke RE, Mahon BE, Griffin PM; Emerging Infections Program Foodnet Working Group (2013) Increased recognition of non-O157 Shiga toxin-producing Escherichia coli infections in the United States during 2000–2010: epidemiologic features and comparison with E. coli O157 infections. Foodborne Pathog Dis 10(5):453–460CrossRefPubMed Gould LH, Mody RK, Ong KL, Clogher P, Cronquist AB, Garman KN, Lathrop S, Medus C, Spina NL, Webb TH, White PL, Wymore K, Gierke RE, Mahon BE, Griffin PM; Emerging Infections Program Foodnet Working Group (2013) Increased recognition of non-O157 Shiga toxin-producing Escherichia coli infections in the United States during 2000–2010: epidemiologic features and comparison with E. coli O157 infections. Foodborne Pathog Dis 10(5):453–460CrossRefPubMed
24.
go back to reference Beutin L, Krause G, Zimmermann S, Kaulfuss S, Gleier K (2004) Characterization of Shiga toxin-producing Escherichia coli strains isolated from human patients in Germany over a 3-year period. J Clin Microbiol 42(3):1099–1108CrossRefPubMedPubMedCentral Beutin L, Krause G, Zimmermann S, Kaulfuss S, Gleier K (2004) Characterization of Shiga toxin-producing Escherichia coli strains isolated from human patients in Germany over a 3-year period. J Clin Microbiol 42(3):1099–1108CrossRefPubMedPubMedCentral
25.
go back to reference Byrne L, Vanstone GL, Perry NT, Launders N, Adak GK, Godbole G, Grant KA, Smith R, Jenkins C (2014) Epidemiology and microbiology of Shiga toxin-producing Escherichia coli other than serogroup O157 in England, 2009–2013. J Med Microbiol 63(Pt 9):1181–1188CrossRefPubMed Byrne L, Vanstone GL, Perry NT, Launders N, Adak GK, Godbole G, Grant KA, Smith R, Jenkins C (2014) Epidemiology and microbiology of Shiga toxin-producing Escherichia coli other than serogroup O157 in England, 2009–2013. J Med Microbiol 63(Pt 9):1181–1188CrossRefPubMed
27.
go back to reference Bettelheim KA, Whipp M, Djordjevic SP, Ramachandran V (2002) First isolation outside Europe of sorbitol-fermenting verocytotoxigenic Escherichia coli (VTEC) belonging to O group O157. J Med Microbiol 51(8):713–714. doi:10.1099/0022-1317-51-8-713 CrossRefPubMed Bettelheim KA, Whipp M, Djordjevic SP, Ramachandran V (2002) First isolation outside Europe of sorbitol-fermenting verocytotoxigenic Escherichia coli (VTEC) belonging to O group O157. J Med Microbiol 51(8):713–714. doi:10.​1099/​0022-1317-51-8-713 CrossRefPubMed
28.
go back to reference Bielaszewska M, Fell M, Greune L, Prager R, Fruth A, Tschäpe H, Schmidt MA, Karch H (2004) Characterization of cytolethal distending toxin genes and expression in Shiga toxin-producing Escherichia coli strains of non-O157 serogroups. Infect Immun 72(3):1812–1816CrossRefPubMedPubMedCentral Bielaszewska M, Fell M, Greune L, Prager R, Fruth A, Tschäpe H, Schmidt MA, Karch H (2004) Characterization of cytolethal distending toxin genes and expression in Shiga toxin-producing Escherichia coli strains of non-O157 serogroups. Infect Immun 72(3):1812–1816CrossRefPubMedPubMedCentral
31.
go back to reference Imamovic L, Tozzoli R, Michelacci V, Minelli F, Marziano ML, Caprioli A, Morabito S (2010) OI-57, a genomic island of Escherichia coli O157, is present in other seropathotypes of Shiga toxin-producing E. coli associated with severe human disease. Infect Immun 78(11):4697–4704. doi:10.1128/IAI.00512-10 CrossRefPubMedPubMedCentral Imamovic L, Tozzoli R, Michelacci V, Minelli F, Marziano ML, Caprioli A, Morabito S (2010) OI-57, a genomic island of Escherichia coli O157, is present in other seropathotypes of Shiga toxin-producing E. coli associated with severe human disease. Infect Immun 78(11):4697–4704. doi:10.​1128/​IAI.​00512-10 CrossRefPubMedPubMedCentral
33.
go back to reference Konczy P, Ziebell K, Mascarenhas M, Choi A, Michaud C, Kropinski AM, Whittam TS, Wickham M, Finlay B, Karmali MA (2008) Genomic O island 122, locus for enterocyte effacement, and the evolution of virulent verocytotoxin-producing Escherichia coli. J Bacteriol 190(17):5832–5840. doi:10.1128/JB.00480-08 CrossRefPubMedPubMedCentral Konczy P, Ziebell K, Mascarenhas M, Choi A, Michaud C, Kropinski AM, Whittam TS, Wickham M, Finlay B, Karmali MA (2008) Genomic O island 122, locus for enterocyte effacement, and the evolution of virulent verocytotoxin-producing Escherichia coli. J Bacteriol 190(17):5832–5840. doi:10.​1128/​JB.​00480-08 CrossRefPubMedPubMedCentral
34.
go back to reference Hemrajani C, Marches O, Wiles S, Girard F, Dennis A, Dziva F, Best A, Phillips AD, Berger CN, Mousnier A, Crepin VF, Kruidenier L, Woodward MJ, Stevens MP, La Ragione RM, MacDonald TT, Frankel G (2008) Role of NleH, a type III secreted effector from attaching and effacing pathogens, in colonization of the bovine, ovine, and murine gut. Infect Immun 76(11):4804–4813. doi:10.1128/IAI.00742-08 CrossRefPubMedPubMedCentral Hemrajani C, Marches O, Wiles S, Girard F, Dennis A, Dziva F, Best A, Phillips AD, Berger CN, Mousnier A, Crepin VF, Kruidenier L, Woodward MJ, Stevens MP, La Ragione RM, MacDonald TT, Frankel G (2008) Role of NleH, a type III secreted effector from attaching and effacing pathogens, in colonization of the bovine, ovine, and murine gut. Infect Immun 76(11):4804–4813. doi:10.​1128/​IAI.​00742-08 CrossRefPubMedPubMedCentral
37.
go back to reference Haugum K, Brandal LT, Lindstedt BA, Wester AL, Bergh K, Afset JE (2014) PCR-based detection and molecular characterization of shiga toxin-producing Escherichia coli strains in a routine microbiology laboratory over 16 years. J Clin Microbiol 52(9):3156–3163. doi:10.1128/JCM.00453-14 CrossRefPubMedPubMedCentral Haugum K, Brandal LT, Lindstedt BA, Wester AL, Bergh K, Afset JE (2014) PCR-based detection and molecular characterization of shiga toxin-producing Escherichia coli strains in a routine microbiology laboratory over 16 years. J Clin Microbiol 52(9):3156–3163. doi:10.​1128/​JCM.​00453-14 CrossRefPubMedPubMedCentral
Metadata
Title
Virulence factors of Shiga toxin-producing Escherichia coli and the risk of developing haemolytic uraemic syndrome in Norway, 1992–2013
Authors
U. Naseer
I. Løbersli
M. Hindrum
T. Bruvik
L. T. Brandal
Publication date
01-09-2017
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 9/2017
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-017-2974-z

Other articles of this Issue 9/2017

European Journal of Clinical Microbiology & Infectious Diseases 9/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.